Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genus (GNS) Share Price

Price 2,670.00p on 13-03-2026 at 19:40:07
Change -25.00p -0.93%
Buy 2,680.00p
Sell 2,670.00p
Last Trade: Unknown 243.00 at 2,664.272p
Day's Volume: 44,063
Last Close: 2,670.00p
Open: 2,675.00p
ISIN: GB0002074580
Day's Range 2,650.00p - 2,695.00p
52wk Range: 1,548.00p - 3,220.00p
Market Capitalisation: £1.77b
VWAP: 2,670.68842p
Shares in Issue: 66.41m

Genus (GNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 243 2,664.272p SI Trade
Negotiated Trade
16:47:07 - 13-Mar-26
Unknown* 140 2,670.00p SI Trade
16:35:25 - 13-Mar-26
Sell* 20,580 2,670.00p Uncrossing Trade
16:35:25 - 13-Mar-26
Unknown* 1 2,675.00p SI Trade
16:29:51 - 13-Mar-26
Buy* 20 2,680.00p Automatic Execution
16:29:50 - 13-Mar-26
Buy* 36 2,680.00p Automatic Execution
16:29:50 - 13-Mar-26
Buy* 28 2,680.00p Automatic Execution
16:29:50 - 13-Mar-26
Sell* 27 2,675.00p Automatic Execution
16:29:37 - 13-Mar-26
Sell* 21 2,675.00p Automatic Execution
16:29:37 - 13-Mar-26
Buy* 27 2,680.00p Automatic Execution
16:29:37 - 13-Mar-26
See more Genus trades

Genus (GNS) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Mar 2026 (Fri) 2,675.00 2,695.00 2,650.00 2,670.00 44,063
12th Mar 2026 (Thu) 2,685.00 2,710.00 2,655.00 2,695.00 558,910
11th Mar 2026 (Wed) 2,665.00 2,730.00 2,650.00 2,685.00 113,005
10th Mar 2026 (Tue) 2,710.00 2,750.00 2,695.00 2,740.00 407,027
9th Mar 2026 (Mon) 2,615.00 2,670.00 2,575.00 2,645.00 147,197
6th Mar 2026 (Fri) 2,710.00 2,710.00 2,655.00 2,670.00 69,182
5th Mar 2026 (Thu) 2,745.00 2,760.00 2,680.00 2,680.00 75,060
4th Mar 2026 (Wed) 2,780.00 2,785.00 2,715.00 2,740.00 127,541
3rd Mar 2026 (Tue) 2,840.00 2,855.00 2,720.00 2,800.00 204,105
2nd Mar 2026 (Mon) 2,940.00 2,940.00 2,855.00 2,880.00 130,600
27th Feb 2026 (Fri) 2,850.00 2,970.00 2,850.00 2,915.00 251,318
26th Feb 2026 (Thu) 3,170.00 3,170.00 2,810.00 2,840.00 383,523
25th Feb 2026 (Wed) 3,165.00 3,215.00 3,160.00 3,170.00 185,533
24th Feb 2026 (Tue) 3,125.00 3,220.00 3,125.00 3,155.00 138,663
23rd Feb 2026 (Mon) 3,190.00 3,190.00 3,115.00 3,135.00 36,561
20th Feb 2026 (Fri) 3,130.00 3,175.00 3,115.00 3,135.00 55,901
19th Feb 2026 (Thu) 3,135.00 3,135.00 3,060.00 3,120.00 239,411
18th Feb 2026 (Wed) 3,110.00 3,135.00 3,070.00 3,130.00 49,974
17th Feb 2026 (Tue) 3,110.00 3,110.00 3,005.00 3,075.00 56,836
16th Feb 2026 (Mon) 3,015.00 3,065.00 3,005.00 3,025.00 42,751
13th Feb 2026 (Fri) 3,055.00 3,055.00 2,985.00 3,030.00 173,132
See more Genus price history

Genus (GNS) Regulatory News

Date Source Headline
10th Mar 2026 3:56 pm RNS Notification of Major Holdings
10th Mar 2026 3:56 pm RNS Notification of Major Holdings
4th Mar 2026 10:33 am RNS Director/PDMR Shareholding
4th Mar 2026 10:08 am RNS Director Declaration
27th Feb 2026 12:48 pm RNS Director/PDMR Shareholding
26th Feb 2026 7:00 am RNS Interim Results
2nd Feb 2026 12:39 pm RNS Block Listing Return
2nd Feb 2026 11:21 am RNS Total Voting Rights
2nd Feb 2026 7:00 am RNS Successful formation of Chinese porcine JV
23rd Jan 2026 5:23 pm RNS PRP Regulatory Progress – Canada
See more Genus regulatory news

Genus (GNS) Share News

Genus says entering second half confidently but notes challenges

26th Feb 2026 11:06

(Alliance News) - Genus PLC on Thursday noted a challenging period for European dairy and beef producer profits while local dairy producers in China faced weak demand and low milk prices. Read More

LONDON BROKER RATINGS: Santander cuts BP; Berenberg likes Cairn Homes

26th Feb 2026 09:59

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

Genus completes formation of Chinese porcine joint venture

2nd Feb 2026 12:42

(Alliance News) - Genus PLC on Monday said it has successfully formed its Chinese porcine joint venture, seeing the move as the "the best platform" to drive growth at PIC China. Read More

LONDON BRIEFING: UK house price growth rises; AstraZeneca joins NYSE

2nd Feb 2026 07:56

(Alliance News) - UK annual house price growth rises more than expected in January, while AstraZeneca starts trading in New York and FitzWalter Capital says it does not intend to make an offer for Auction Technology Group. Read More

LONDON BRIEFING: GSK wins EU nod for RSV shot; Spire in early talks

26th Jan 2026 07:59

(Alliance News) - GSK wins EU approval to expand use of its RSV vaccine Arexvy to all adults over 18, while Grainger unveils plans for a 195-home West London development, and Impax Environmental Markets outlines its tender offer plan amid continued pressure from activist investor Saba. Read More

See more Genus news
FTSE 100 Latest
Value10,261.15
Change-44.00

Login to your account

Forgot Password?

Not Registered